At present, most available biopharmaceutics are produced from cultured animal cells. However, one of the big problems of this producing systems is high production cost due to the difficulty of purification of pharmaceutics from the complex ingredients...
At present, most available biopharmaceutics are produced from cultured animal cells. However, one of the big problems of this producing systems is high production cost due to the difficulty of purification of pharmaceutics from the complex ingredients of culture medium. As a promising solution for this problem, use of “bioreactors” to address the growing demand for large quantities and increasing number of biopharmaceuticals is of prime strategic relevance to medical advancement. Most recently, chickens have been proposed as a highly efficient animal for the production of pharmaceutical proteins versus mammary gland based bioreactors. Some of the advantages of a chicken bioreactor system over its mammalian counterpart include shorter generation time, lower breeding expense and fecundity of chickens.
Transgenic chicken studies have been performed for this doctorate dissertation. In the fist study, tetracycline-inducible expression system was examined to determine whether it could regulate expression of a foreign protein in a transgenic chicken model. This is because uncontrolled constitutive expression of foreign proteins has been known to cause serious physiological disturbances in transgenic animals. The use of a tetracycline-inducible expression system in transgenic chickens represents a potentially viable approach to two competing endpoints: maximal transgene expression with minimal physiological dysfunctions. I have demonstrated successful inducible expression of a transgene encoding green fluorescent protein (GFP) in transgenic chickens by feeding with doxycycline, a tetracycline derivative, and complete reversion of the induced GFP expression to pre-induction level when the inducer was removed from the diet. In addition, stable germline transmission of the exogenous transgene was confirmed in progeny chickens. In the second study, I have designed recombinant secretory EGFP (EGFPSec) in which the signal peptide sequence of the rat follicle-stimulating hormone (FSH) β-subunit was fused upstream of EGFP. Efficient secretion of the modified EGFP has been found in several cell types. Consequently, the level of the gene expression was able to be easily quantified. Application of our modified EGFP expression cassette will also be very helpful in the study of transgenic livestock intended to use as bioreactors for mass production of pharmaceuticals. The results obtained from this two main studies demonstrate the possible use of chicken as bioreactor producing foreign proteins. In addition, these results also significantly provide basic scientific knowledge in avian reproductive physiology.